{
  "id": 5450677,
  "title": "Mpm Bioventures, 10% owner, sells $617k in Entrada Therapeutics",
  "url": "https://urgent.news/2026/09/04/mpm-bioventures-10-owner-sells-617k-in-entrada-therapeutics",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-04T00:16:03.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/mpm-bioventures-10-owner-sells-617k-in-entrada-therapeutics-93CH-4888719"
  },
  "original_language": "en",
  "account": "MPM BioVentures, a 10% shareholder in Entrada Therapeutics, conducted a series of stock sales totaling $617,378 between September 1 and September 3, 2026. The transactions saw shares exchanged at prices between $7.06 and $7.19 per share, with individual sales ranging from $6.80 to $7.405. On September 1, 29,088 shares were sold at an average price of $7.06, followed by 25,131 shares traded at $7.19 on September 2 and a final sale of 32,263 shares at $7.17 on September 3. This resulted in a total of 86,482 shares changing hands across the three-day period. The company now holds 4,144,952 shares of Entrada Therapeutics common stock, outpacing its debt. Analysts suggest the stock is undervalued, with MPM BioVentures citing 6 InvestingPro Tips for further insights. The sales were orchestrated by various MPM BioVentures entities, including MPM BioVentures 2014, L.P., MPM BioVentures 2018, L.P., and their affiliates, managed by Messrs. Evnin, Foley, and Gadicke.",
  "summary": null,
  "key_points": [
    "MPM BioVentures sold $617,378 worth of Entrada Therapeutics stock",
    "Transactions occurred September 1-3, 2026 at $7.06-$7.19 per share",
    "MPM BioVentures now owns 4.14 million shares of Entrada Therapeutics"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Mpm Bioventures 2018 sells $617k Entrada Therapeutics shares",
        "url": "https://urgent.news/2026/09/04/mpm-bioventures-2018-sells-617k-entrada-therapeutics-shares",
        "published": "2026-09-04T00:20:20.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}